mequinol has been researched along with tretinoin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Nair, X; Tramposch, KM | 1 |
| Oliver, I; Sherbet, GV; Thody, AJ | 1 |
| Nair, X; Parab, P; Suhr, L; Tramposch, KM | 1 |
| Altman, DJ; Colby, SI; Fleischer, AB; Schwartzel, EH | 1 |
| Chando, TJ; D'Arienzo, CJ; Everett, DW; Franz, TJ; Gale, PJ; Kripalani, KJ; Lehman, PA; Parab, PV; Schwarzel, EH | 1 |
| Aslani, FS; Handjani, F; Kasraee, B | 1 |
| Altman, DJ; Colby, SI; Epinette, WW; Highton, A; Huber, FJ; Lyon, E; Schwartzel, EH | 1 |
| Bergfelt, L; Camacho, F; Ortonne, JP; Roseeuw, D; Wainwright, N; Westerhof, W | 1 |
| Jarratt, M | 1 |
| Draelos, ZD | 1 |
| Benitez, A; Cardona, L; Epstein, R; Keeling, J; Rendon, M | 1 |
| Henry, F; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P; Vroome, V | 1 |
| Friedman, Y | 1 |
2 review(s) available for mequinol and tretinoin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.
Topics: Administration, Topical; Adult; Anisoles; Antioxidants; Facial Dermatoses; Humans; Keratolytic Agents; Male; Melanosis; Middle Aged; Solutions; Treatment Outcome; Tretinoin | 2008 |
5 trial(s) available for mequinol and tretinoin
| Article | Year |
|---|---|
The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Antioxidants; Arm; Double-Blind Method; Drug Therapy, Combination; Facial Dermatoses; Female; Hand Dermatoses; Humans; Hyperpigmentation; Keratolytic Agents; Lentigo; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Tretinoin | 2000 |
Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.
Topics: Administration, Cutaneous; Adult; Anisoles; Dermatologic Agents; Female; Humans; Hypopigmentation; Keratolytic Agents; Lentigo; Male; Severity of Illness Index; Sunscreening Agents; Time Factors; Treatment Outcome; Tretinoin | 2004 |
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Therapy, Combination; Face; Female; Forearm; Humans; Hydroquinones; Keratolytic Agents; Lentigo; Male; Middle Aged; Treatment Outcome; Tretinoin | 2004 |
The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups.
Topics: Adult; Aged; Aged, 80 and over; Anisoles; Antioxidants; Drug Combinations; Ethnicity; Face; Female; Humans; Keratolytic Agents; Lentigo; Male; Middle Aged; Tretinoin | 2006 |
Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Aged; Anisoles; Antioxidants; Dermoscopy; Drug Therapy, Combination; Female; Follow-Up Studies; Hand Dermatoses; Humans; Keratolytic Agents; Lentigo; Middle Aged; Skin Aging; Spectrophotometry; Sunlight; Tretinoin; Ultraviolet Rays; Video Recording | 2008 |
8 other study(ies) available for mequinol and tretinoin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
UVB-induced pigmentation in hairless mice as an in vivo assay for topical skin-depigmenting activity.
Topics: Animals; Anisoles; Female; Hydroquinones; Mice; Mice, Hairless; Pyrones; Skin; Skin Pigmentation; Tretinoin; Ultraviolet Rays | 1989 |
Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
Topics: Animals; Anisoles; Catechol Oxidase; Cell Survival; Ditiocarb; Melanocyte-Stimulating Hormones; Melanoma; Mice; Monophenol Monooxygenase; Tretinoin; Tumor Cells, Cultured | 1988 |
Combination of 4-hydroxyanisole and all-trans retinoic acid produces synergistic skin depigmentation in swine.
Topics: Animals; Anisoles; Drug Synergism; Mice; Mice, Hairless; Skin; Skin Absorption; Skin Pigmentation; Swine; Swine, Miniature; Tretinoin; Ultraviolet Rays | 1993 |
Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé) solution in healthy volunteers.
Topics: Administration, Topical; Adult; Animals; Anisoles; Antineoplastic Agents; Area Under Curve; Drug Combinations; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Male; Mice; Middle Aged; Rats; Skin Absorption; Tretinoin | 1999 |
Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection?
Topics: Animals; Anisoles; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Guinea Pigs; Humans; Hydroquinones; Keratolytic Agents; Melanocytes; Skin Pigmentation; Swine; Tretinoin | 2003 |
A promising new treatment for solar lentigines.
Topics: Adult; Aged; Aged, 80 and over; Anisoles; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperpigmentation; Male; Middle Aged; Sunscreening Agents; Tretinoin | 2003 |
Two drugs facing key patent expirations and potential generic entry from July to August 2020.
Topics: Anisoles; Ciprofloxacin; Dexamethasone; Drug Combinations; Drug Industry; Drugs, Generic; Humans; Patents as Topic; Tretinoin; United States | 2020 |